Prime posizioni
| # | Nome | Peso |
|---|---|---|
| 1 | Compass Pathways Plc | 11.06% |
| 2 | Relmada Therapeutics Inc | 7.81% |
| 3 | NRX Pharmaceuticals Inc | 7.08% |
| 4 | GH Research PLC | 5.30% |
| 5 | Alkermes Plc | 4.80% |
| 6 | Neurocrine Biosciences Inc | 4.66% |
| 7 | AbbVie Inc | 4.33% |
| 8 | Johnson & Johnson | 3.92% |
| 9 | Alto Neuroscience, Inc. | 3.83% |
| 10 | Supernus Pharmaceuticals Inc | 3.48% |
Ripartizione geografica
Ripartizione settoriale
100.0%
Performance e rischio
Rendimenti, volatilità e dividendi — in arrivo